|
BAHD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.04179997540666E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.40260003401016E-09 |
| Normal-vs-Stage2 |
1.35540000001377E-06 |
| Normal-vs-Stage3 |
4.31310000004181E-06 |
| Normal-vs-Stage4 |
1.72014999999526E-05 |
| Stage1-vs-Stage2 |
7.691800E-01 |
| Stage1-vs-Stage3 |
7.898800E-01 |
| Stage1-vs-Stage4 |
1.348850E-01 |
| Stage2-vs-Stage3 |
9.649200E-01 |
| Stage2-vs-Stage4 |
2.134000E-01 |
| Stage3-vs-Stage4 |
2.722200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.49090001139763E-09 |
| Normal-vs-AfricanAmerican |
1.32649999995404E-06 |
| Normal-vs-Asian |
8.723900E-03 |
| Caucasian-vs-AfricanAmerican |
5.958000E-01 |
| Caucasian-vs-Asian |
9.236400E-01 |
| AfricanAmerican-vs-Asian |
9.283200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.21080001580509E-09 |
| Normal-vs-Female |
5.7477000000028E-05 |
| Male-vs-Female |
9.890200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.85100000052552E-07 |
| Normal-vs-Extreme_Weight |
8.19309999844364E-08 |
| Normal-vs-Obese |
1.62029999994928E-06 |
| Normal-vs-Extreme_Obese |
7.083200E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.475800E-01 |
| Normal_Weight-vs-Obese |
3.132200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.598000E-01 |
| Extreme_Weight-vs-Obese |
3.505200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.095000E-01 |
| Obese-vs-Extreme_Obese |
5.668400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.226600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.51200000001006E-06 |
| Normal-vs-Age(61-80Yrs) |
4.32100022429438E-10 |
| Normal-vs-Age(81-100Yrs) |
3.78530000000321E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.570600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.933600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.286200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.210620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.682400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.757600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.27000000019295E-07 |
| Normal-VS-Type2 PRCC |
1.59950053202351E-10 |
| Normal-VS-KIRP CIMP |
2.36009999999842E-05 |
| Normal-VS-Unclassified PRCC |
2.12219999999874E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.041600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.307200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.323000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.686400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.677630E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.916400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.42279973861059E-10 |
| Normal-vs-N1 |
2.14299999967693E-07 |
| Normal-vs-N2 |
1.393970E-02 |
| N0-vs-N1 |
9.183600E-01 |
| N0-vs-N2 |
5.683400E-01 |
| N1-vs-N2 |
7.117000E-01 |
|
|
